Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Mathew

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Cell|October 23, 2012
Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFβ suppressionMichael Ginsberg, Daylon James, Bi-Sen Ding, et al.
Cancer Discovery|August 2, 2014
Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphomaDavid Chiron, Maurizio Di Liberto, Peter Martin, et al.
Cold Spring Harbor Molecular Case Studies|December 28, 2022
Whole-genome characterization of myoepithelial carcinomas of the soft tissueJoanna Cyrta, Joel Rosiene, Rohan Bareja, et al.
Neurology India|July 13, 2025
Incidence, Risk Factors, and Complications of Dysphagia in Stroke Patients Admitted to Medical Wards at a Tertiary Hospital in South IndiaDvs Kiran Kumar, Asisha Mathensingh, Muruga Bharathy Kalimuthu, et al.
American Journal of Clinical Pathology|April 5, 2017
Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter StudyHeesun J Rogers, Eric D Hsi, Guilin Tang, et al.
Nature|March 9, 2007
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemiaCharles G Mullighan, Salil Goorha, Ina Radtke, et al.
Blood Advances|October 26, 2020
Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypesHanna Scholze, Regan E Stephenson, Raymond Reynolds, et al.
Blood Advances|September 22, 2021
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasmOriana Miltiadous, Kseniya Petrova-Drus, Shipra Kaicker, et al.
Blood|October 15, 2015
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcriptsIrene Scarfò, Elisa Pellegrino, Elisabetta Mereu, et al.
Haematologica|January 28, 2014
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group studyHeesun J Rogers, James W Vardiman, John Anastasi, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Cell|October 23, 2012
Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFβ suppressionMichael Ginsberg, Daylon James, Bi-Sen Ding, et al.
Cancer Discovery|August 2, 2014
Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphomaDavid Chiron, Maurizio Di Liberto, Peter Martin, et al.
Cold Spring Harbor Molecular Case Studies|December 28, 2022
Whole-genome characterization of myoepithelial carcinomas of the soft tissueJoanna Cyrta, Joel Rosiene, Rohan Bareja, et al.
Neurology India|July 13, 2025
Incidence, Risk Factors, and Complications of Dysphagia in Stroke Patients Admitted to Medical Wards at a Tertiary Hospital in South IndiaDvs Kiran Kumar, Asisha Mathensingh, Muruga Bharathy Kalimuthu, et al.
American Journal of Clinical Pathology|April 5, 2017
Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter StudyHeesun J Rogers, Eric D Hsi, Guilin Tang, et al.
Nature|March 9, 2007
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemiaCharles G Mullighan, Salil Goorha, Ina Radtke, et al.
Blood Advances|October 26, 2020
Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypesHanna Scholze, Regan E Stephenson, Raymond Reynolds, et al.
Blood Advances|September 22, 2021
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasmOriana Miltiadous, Kseniya Petrova-Drus, Shipra Kaicker, et al.
Blood|October 15, 2015
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcriptsIrene Scarfò, Elisa Pellegrino, Elisabetta Mereu, et al.
Haematologica|January 28, 2014
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group studyHeesun J Rogers, James W Vardiman, John Anastasi, et al.
Pageof 11